Greenbrook Tms announced it raised $15.7 Million in an initial filing from an offering of $15.7 Million
Greenbrook Tms announced it raised $15.7 Million in an initial filing from an offering of $15.7 Million
07/28/22, 8:48 PM
Location
torontoMoney raised
$15.7 million
Industry
medical
biotechnology
health care
Company Info
Location
890 yonge street, 7th floor
toronto, ontario, canada
Additional Info
Greenbrook TMS Inc. is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato® (esketamine nasal spray), FDA-cleared and non-invasive therapies for the treatment of Major Depressive Disorder (MDD) and other mental health disorders in the United States. The company operates through 130 Company-operated treatment centers and has provided more than 1.3 million treatments to over 40,000 patients struggling with depression.